Verastem Oncology (VSTM) Misses Q1 EPS by 43c
Tweet
Share
E-mailGet Alerts VSTM Hot Sheet
Join SI Premium – FREE
Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.43). Revenue for the quarter came in at $18.67 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen Group Resumes Illumina (ILMN) at Market Perform
- Western Digital (WDC) call put ratio 1.1 calls to 1 put
- Goldman Sachs Starts PENN Entertainment (PENN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
